Labeler
Cipla USA Inc. NDC Codes
Cipla USA Inc. lists 269 finished drug products in the FDA NDC Directory under NDC labeler code 69097.
Overview
Each product below links to its own NDC page with package NDCs in 10- and 11-digit form.
- Drugs
- Lanreotide Acetate, Diltiazem Hydrochloride, Lenalidomide, Lurasidone Hydrochloride, Pomalidomide, Phytonadione, Pravastatin Sodium, Fluticasone propionate and Salmeterol, Nilotinib, Potassium Phosphates, Vilazodone Hydrochloride, Pirfenidone, Deferasirox, Lanthanum carbonate, Dapagliflozin
- Active ingredients
- Lanreotide acetate, Diltiazem hydrochloride, Lenalidomide, Lurasidone hydrochloride, Pomalidomide, Phytonadione, Pravastatin sodium, Fluticasone propionate, Salmeterol xinafoate, Nilotinib, Monobasic potassium phosphate, Dibasic potassium phosphate
- NDC labeler codes
- 69097
- Strengths (from the 100 most recently listed products)
- Salmeterol xinafoate 50 ug/1; Monobasic potassium phosphate 224 mg/mL; Dibasic potassium phosphate 236 mg/mL; Liraglutide 6 mg/mL; Lanreotide acetate 120 mg/.5mL; Lanreotide acetate 60 mg/.2mL; Lanreotide acetate 90 mg/.3mL; Phytonadione 1 mg/.5mL; Pirfenidone 267 mg/1; Cyclosporine .5 mg/mL; Pomalidomide 1 mg/1; Pomalidomide 2 mg/1; Pomalidomide 3 mg/1; Pomalidomide 4 mg/1; Fluticasone propionate 250 ug/1; Fluticasone propionate 100 ug/1; Fluticasone propionate 500 ug/1; Albuterol sulfate 90 ug/1; Dapagliflozin propanediol 5 mg/1; Dapagliflozin propanediol 10 mg/1
- Dosage forms
- Capsule, Tablet, Film coated, Injection, Tablet, Tablet, Extended release, Powder, Injection, Solution, Injection, Emulsion, For suspension, Granule, Tablet, Chewable, Emulsion, Kit, Suspension, Tablet, Film coated, Extended release, Tablet, Coated, Aerosol, Metered, Injection, Powder, Lyophilized, For suspension, Gel, Granule, For solution, Solution
- Routes
- Oral, Subcutaneous, Intravenous, Intramuscular, Respiratory (Inhalation), Ophthalmic, Topical
- Drug classes (FDA established)
- Thalidomide Analog, Somatostatin Analog, Osmotic Laxative, Potassium Salt, Calcium Channel Blocker, beta2-Adrenergic Agonist, Kinase Inhibitor, Atypical Antipsychotic, Corticosteroid, Vitamin K, Warfarin Reversal Agent, HMG-CoA Reductase Inhibitor, Proton Pump Inhibitor, Protease Inhibitor, Pyridone, Iron Chelator, Phosphate Binder, Sodium-Glucose Cotransporter 2 Inhibitor, GLP-1 Receptor Agonist, Leukocyte Growth Factor, P2Y12 Platelet Inhibitor, Serotonin Reuptake Inhibitor, Serotonin-4 Receptor Agonist, Dihydropyridine Calcium Channel Blocker, Aminoketone, Androgen, Nucleoside Metabolic Inhibitor, Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor, Calcineurin Inhibitor Immunosuppressant, Microtubule Inhibitor, Penicillin-class Antibacterial, beta Lactamase Inhibitor, Calcitonin, Nonsteroidal Anti-inflammatory Drug, Muscle Relaxant, Neuraminidase Inhibitor, Cytochrome P450 3A Inhibitor, Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor
- HCPCS / J-code
- None in Med-Code's directory for these products
- Package NDCs
- 136 (from the 100 most recently listed products)
NDC codes
Newest listings first. Each row links to the product’s NDC page.
| Product | Strength | Form · route | Product NDC | Package NDCs (11-digit) | HCPCS |
|---|---|---|---|---|---|
| Tadalafil | Tadalafil 20 mg/1 | Tablet, Film coatedOral | 69097-526 | 69097-0526-0369097-0526-16 | — |
| Cyclophosphamide | Cyclophosphamide 25 mg/1 | CapsuleOral | 69097-516 | 69097-0516-07 | — |
| Cyclophosphamide | Cyclophosphamide 50 mg/1 | CapsuleOral | 69097-517 | 69097-0517-07 | — |
| Zemdri (plazomicin)plazomicin | Plazomicin 500 mg/10mL | InjectionIntravenous | 69097-820 | 69097-0820-96 | — |
| Isoproterenolisoproterenol hydrochloride | Isoproterenol hydrochloride .2 mg/mL | Injection, SolutionIntracardiac, Intramuscular, Intravenous, Subcutaneous | 69097-521 | 69097-0521-31 | — |
| Isoproterenolisoproterenol hydrochloride | Isoproterenol hydrochloride 1 mg/5mL | Injection, SolutionIntracardiac, Intramuscular, Intravenous, Subcutaneous | 69097-522 | 69097-0522-35 | — |
| Efavirenz | Efavirenz 600 mg/1 | Tablet, Film coatedOral | 69097-301 | 69097-0301-02 | — |
| bupropion Hydrochloride | Bupropion hydrochloride 75 mg/1 | TabletOral | 69097-917 | 69097-0917-0269097-0917-0769097-0917-15 | — |
| bupropion Hydrochloride | Bupropion hydrochloride 100 mg/1 | TabletOral | 69097-918 | 69097-0918-0269097-0918-0769097-0918-15 | — |
| Exemestane | Exemestane 25 mg/1 | TabletOral | 69097-316 | 69097-0316-02 | — |
| Testosterone | Testosterone 30 mg/1.5mL | SolutionTopical | 69097-363 | 69097-0363-44 | — |
| palonosetron hydrochloride | Palonosetron hydrochloride .25 mg/5mL | InjectionIntravenous | 69097-927 | 69097-0927-35 | — |
| Cinacalcet | Cinacalcet hydrochloride 30 mg/1 | TabletOral | 69097-410 | 69097-0410-02 | — |
| Cinacalcet | Cinacalcet hydrochloride 60 mg/1 | TabletOral | 69097-411 | 69097-0411-02 | — |
| Cinacalcet | Cinacalcet hydrochloride 90 mg/1 | TabletOral | 69097-412 | 69097-0412-02 | — |
| Tenofovir disoproxil fumarate | Tenofovir disoproxil fumarate 300 mg/1 | TabletOral | 69097-533 | 69097-0533-0269097-0533-15 | — |
| Gabapentin | Gabapentin 300 mg/1 | CapsuleOral | 69097-943 | 69097-0943-0769097-0943-12 | — |
| Abacavir | Abacavir sulfate 300 mg/1 | Tablet, Film coatedOral | 69097-514 | 69097-0514-03 | — |
| Budesonide Inhalation Suspensionbudesonide | Budesonide .25 mg/2mL | InhalantOral | 69097-318 | 69097-0318-5369097-0318-87 | — |
| Budesonide Inhalation Suspensionbudesonide | Budesonide .5 mg/2mL | InhalantOral | 69097-319 | 69097-0319-5369097-0319-87 | — |
| Budesonide Inhalation Suspensionbudesonide | Budesonide 1 mg/2mL | InhalantOral | 69097-321 | 69097-0321-5369097-0321-87 | — |
| Atorvastatin Calcium | Atorvastatin calcium trihydrate 10 mg/1 | Tablet, Film coatedOral | 69097-944 | 69097-0944-0569097-0944-15 | — |
| Atorvastatin Calcium | Atorvastatin calcium trihydrate 20 mg/1 | Tablet, Film coatedOral | 69097-945 | 69097-0945-0569097-0945-12 | — |
| Atorvastatin Calcium | Atorvastatin calcium trihydrate 40 mg/1 | Tablet, Film coatedOral | 69097-946 | 69097-0946-0569097-0946-15 | — |
| Atorvastatin Calcium | Atorvastatin calcium trihydrate 80 mg/1 | Tablet, Film coatedOral | 69097-947 | 69097-0947-0569097-0947-12 | — |
| Sevelamer carbonate | Sevelamer carbonate 800 mg/1 | Tablet, Film coatedOral | 69097-893 | 69097-0893-93 | — |
| Sevelamer carbonate | Sevelamer carbonate 800 mg/1 | Tablet, Film coatedOral | 69097-967 | 69097-0967-93 | — |
| Fenofibrate | Fenofibrate 67 mg/1 | CapsuleOral | 69097-894 | 69097-0894-0269097-0894-0769097-0894-15 | — |
| Fenofibrate | Fenofibrate 134 mg/1 | CapsuleOral | 69097-895 | 69097-0895-0269097-0895-0769097-0895-12 | — |
| Fenofibrate | Fenofibrate 200 mg/1 | CapsuleOral | 69097-896 | 69097-0896-0269097-0896-0769097-0896-12 | — |
| Abacavir and Lamivudine | Abacavir sulfate 600 mg/1; Lamivudine 300 mg/1 | Tablet, Film coatedOral | 69097-362 | 69097-0362-02 | — |
| grisofulvin | Griseofulvin 125 mg/5mL | SuspensionOral | 69097-361 | 69097-0361-08 | — |
| omeprazole sodium bicarbonate | Omeprazole 20 mg/1; Sodium bicarbonate 1100 mg/1 | CapsuleOral | 69097-913 | 69097-0913-0269097-0913-12 | — |
| omeprazole sodium bicarbonate | Omeprazole 40 mg/1; Sodium bicarbonate 1100 mg/1 | CapsuleOral | 69097-914 | 69097-0914-0269097-0914-12 | — |
| Fenofibrate | Fenofibrate 145 mg/1 | TabletOral | 69097-458 | 69097-0458-0269097-0458-05 | — |
| Fenofibrate | Fenofibrate 48 mg/1 | TabletOral | 69097-459 | 69097-0459-0269097-0459-05 | — |
| Entecavir | Entecavir 1 mg/1 | Tablet, Film coatedOral | 69097-425 | 69097-0425-02 | — |
| Entecavir | Entecavir .5 mg/1 | Tablet, Film coatedOral | 69097-426 | 69097-0426-0269097-0426-05 | — |
| Gemfibrozil | Gemfibrozil 600 mg/1 | TabletOral | 69097-821 | 69097-0821-0369097-0821-0769097-0821-12 | — |
| Trospium Chloride | Trospium chloride 20 mg/1 | Tablet, Film coatedOral | 69097-912 | 69097-0912-0269097-0912-0369097-0912-15 | — |
| Darifenacindarifenacin hydrobromide | Darifenacin hydrobromide 7.5 mg/1 | Tablet, Extended releaseOral | 69097-431 | 69097-0431-0269097-0431-0569097-0431-15 | — |
| Darifenacindarifenacin hydrobromide | Darifenacin hydrobromide 15 mg/1 | Tablet, Extended releaseOral | 69097-432 | 69097-0432-0269097-0432-0569097-0432-15 | — |
| Bupropion Hydrochloride (XL)bupropion hydrochloride | Bupropion hydrochloride 150 mg/1 | Tablet, Extended releaseOral | 69097-875 | 69097-0875-0269097-0875-0569097-0875-12 | — |
| Bupropion Hydrochloride (XL)bupropion hydrochloride | Bupropion hydrochloride 300 mg/1 | Tablet, Extended releaseOral | 69097-876 | 69097-0876-0269097-0876-12 | — |
| Atorvastatin Calcium | Atorvastatin calcium trihydrate 10 mg/1 | Tablet, Film coatedOral | 69097-897 | 69097-0897-0569097-0897-15 | — |
| Atorvastatin Calcium | Atorvastatin calcium trihydrate 20 mg/1 | Tablet, Film coatedOral | 69097-898 | 69097-0898-0569097-0898-12 | — |
| Atorvastatin Calcium | Atorvastatin calcium trihydrate 40 mg/1 | Tablet, Film coatedOral | 69097-899 | 69097-0899-0569097-0899-15 | — |
| Atorvastatin Calcium | Atorvastatin calcium trihydrate 80 mg/1 | Tablet, Film coatedOral | 69097-911 | 69097-0911-0569097-0911-12 | — |
| Calcium Acetate | Calcium acetate 667 mg/1 | CapsuleOral | 69097-862 | 69097-0862-0369097-0862-83 | — |
| Bupropion Hydrochloride (SR)bupropion hydrochloride | Bupropion hydrochloride 100 mg/1 | Tablet, Extended releaseOral | 69097-877 | 69097-0877-0269097-0877-0369097-0877-07+1 more | — |
Cipla USA Inc.: common questions
- What is Cipla USA Inc.'s NDC labeler code?
- 69097. The labeler code is the first segment of each NDC. About labeler codes.
- Is there a J-code for Cipla USA Inc.?
- Med-Code's curated HCPCS directory has no drug-specific code for these products. Drugs dispensed by a pharmacy are billed by NDC. NDC vs J-code.
- Which NDC goes on a claim?
- The package NDC of what was given, in 11-digit form. How to convert a 10-digit NDC.